Literature DB >> 12026031

The role of human milk in necrotizing enterocolitis.

Michael S Caplan1, Michael Amer, Tamas Jilling.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12026031     DOI: 10.1007/978-1-4615-0559-4_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  6 in total

1.  Risk factors and outcome in neonatal necrotising enterocolitis.

Authors:  Bahubali Gane; B Vishnu Bhat; B Adhisivam; Rojo Joy; P Prasadkumar; P Femitha; B Shruti
Journal:  Indian J Pediatr       Date:  2014-01-04       Impact factor: 1.967

Review 2.  Impact of standardised feeding regimens on incidence of neonatal necrotising enterocolitis: a systematic review and meta-analysis of observational studies.

Authors:  S K Patole; N de Klerk
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-03       Impact factor: 5.747

Review 3.  Current Knowledge of Necrotizing Enterocolitis in Preterm Infants and the Impact of Different Types of Enteral Nutrition Products.

Authors:  Jocelyn Shulhan; Bryan Dicken; Lisa Hartling; Bodil Mk Larsen
Journal:  Adv Nutr       Date:  2017-01-17       Impact factor: 8.701

Review 4.  Necrotizing enterocolitis: a multifactorial disease with no cure.

Authors:  Kareena-L Schnabl; John-E Van Aerde; Alan-Br Thomson; Michael-T Clandinin
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

5.  Does the use of glycerin laxatives decrease feeding intolerance in preterm infants?

Authors:  Vibhuti Shah; Nevart Chirinian; Shoo Lee
Journal:  Paediatr Child Health       Date:  2011-11       Impact factor: 2.253

6.  Elevated Coefficient of Variation in Total Fecal Bile Acids Precedes Diagnosis of Necrotizing Enterocolitis.

Authors:  Shannon Knapp; Allysa Kehring; Jennifer Stepp; Christine M Calton; Sheila M Gephart; Sruti Bandlamuri; Kate E Boyle; Grey I Dietz; Haeley Johnson; Ryan E Romo; Mackenzie Spencer; Alan D Bedrick; Melissa D Halpern
Journal:  Sci Rep       Date:  2020-01-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.